(Q73497714)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

E Wallström

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

F Piehl

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Di Marco

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

T Olsson

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

number of pages

9

1 reference

Journal of Neuroimmunology

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

202-210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696916%20AND%20SRC:MED&resulttype=core&format=json

Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cells

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

The molecular cell biology of interferon-gamma and its receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Expression of human immune interferon cDNA in E. coli and monkey cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Detection of intracellular expression and secretion of interferon-γ at the single-cell level after activation of human T cells with tetanus toxoidin vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Letter: Substitute for benzidine in myeloperoxidase stains

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Organ-specific autoantigens induce interferon-gamma and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Influence of IFN-beta1b (Betaferon) on cytokine mRNA profiles in blood mononuclear cells and plasma levels of soluble VCAM-1 in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Critical Influences of the Cytokine Orchestration on the Outcome of Myelin Antigen‐Specific T‐Cell Autoimmunity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type II

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Exacerbations of multiple sclerosis in patients treated with gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Recombinant Interferon-β blocks proliferation but enhances interleukin-10 secretion by activated human T-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

The interferons: biological effects, mechanisms of action, and use in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Comparative study of the pharmacodynamic and pharmacologic effects of Betaseron and AVONEX.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900184-8

7 January 2021

10.1016/S0165-5728(99)00184-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10696916%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference